Oh yes ... this one
https://www.********/investing/2020/12/15/why-mesoblast-stock-is-tanking-today/
However, Mesoblast did find some positives in its clinical trial. The Australia-based biotech stated that patients in the study achieved a 60% reduction in the incidence of heart attacks or strokes, as well as a 60% reduction in death from cardiac causes when treated early with Revascor in combination with other therapies.
Mesoblast CEO Silviu Itescu highlighted these positives, stating, "The reduction in mortality seen with rexlemestrocel-L in advanced chronic heart failure underlines the power of this technology and the commitment of Mesoblast to address diseases in patients with high unmet need which are refractory to existing therapies."
Ann: Trading halt, page-401
-
- There are more pages in this discussion • 396 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |